Regulatory Affairs, Compliance Assurance, Quality Systems, Remediation Strategy and Support, and Strategic Consulting Services

Similar documents
An Introduction to Double Dragon Consulting

An Introduction to Double Dragon Consulting

Jeff Yuen and Associates, Inc. PO Box 6026 Orange, CA Zenaida Power Regulatory Expertise:

Sr. Vice President, Global Regulatory Affairs and Quality Assurance AREAS OF EXPERTISE

Drug Development Services

Senior Regulatory Affairs Executive AREAS OF EXPERTISE

Conducted Under an IND to Support a

GxP Auditing, Remediation, and Staff Augmentation

Curriculum Vitae. SENIOR VICE PRESIDENT JAMES P. KULLA Mobile Phone:

GxP Auditing, Remediation, and Quality System Resourcing

Margit Schwalbe-Fehl, Ph.D.

Emerging Trends in Regulatory Outsourcing WHITE PAPER.

Your Complete Quality Solution Provider for the Life Science Industry

BCS Organizational Chart

CONTRACT RESEARCH SERVICES

James B. Powers, Jr. MSA, BS-BioChem Managing Partner, BAI

James B. Powers, Jr. MSA, BS-BioChem Partner. James Powers is a Quality, Compliance and Lean Leader with over 25 years of pharmaceutical experience.

GxP Auditing, Remediation, and Staff Augmentation

GMP The Other Side of Chemistry, Manufacturing & Controls (CMC)

DIFFERING CMC REQUIREMENTS: US AND EU

The In Vitro Diagnostic CRO

1. Clinical Program Manager (ideally based in greater Boston, MA, USA area)

EXPERT ISE YOU CAN TRUST

Stability Testing for Pre-Clinical and Early Phase Clinical Drug Products

3M Drug Delivery Systems. April 26, 2011

FOREIGN DRUG INSPECTION/AUDITS FROM THE FDA PERSPECTIVE

Risk Based Incoming Quality Assurance (IQA)

COMBINATION PRODUCTS Inspection Readiness and Outcomes

Pharmaceutical Good Manufacturing Practice. Contents are subject to change. For the latest updates visit

Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs)

Anushri Global Pharma Consultants

Designing and Sustaining New and Existing Product Stability Testing Program

Textvergleich. Verglichene Dokumente MEDIA3917.pdf. ICH_Q10_Step4.pdf

Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (COM) COURSE DESCRIPTION

EU and FDA GMP Regulations: Overview and Comparison

While the recognition

Edward R. Arling P.O. Box 1536 * Lyons, CO / *

Wilson-Hurd ATF Quality Manual

PRAXIS. A publication by Bioengineering AG

Q10 PHARMACEUTICAL QUALITY SYSTEM

KINGSMANN CARE GROUP

CDER 2016 Actions and 2017 Priorities. Richard Moscicki Deputy Center Director for Science Operations, CDER, FDA

Effectively Addressing and Remediating FDA's Form 483 Findings, Warning Letters and Consent Decree Compliance Issues

2013 Metrics on Human Research Protection Program Performance

ADB Consulting & CRO Inc.

James B. Powers, Jr. MSA, BS-BioChem Managing Partner

Subpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit.

2 DAY WORKSHOP on Preparing For The New EU Medical Device Regulations (MDR)

2 DAY WORKSHOP on Preparing For The New EU Medical Device Regulations (MDR)

Mark D. Kramer, RAC Regulatory Strategies, Inc.

Impact factor: 3.958/ICV: 4.10 ISSN:

Prevent Quality System Deficiencies by Conducting Effective Internal Audits. Whitepaper

Medical Device Communiqué

Technology Transfer Critical Points to Consider

Quality Management System MANUAL. SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702

CANADA (HEALTH CANADA)

NUVISAN GROUP. Our Philosophy

Quality and GMP Compliance for Virtual Companies (Pharmaceutical, Medical Device & Biologics Industries)

Your bridge to. better medicines

An integrated model approach to improve the management of marketed products

Korea GMP & DMF. April Korea Pharmaceutical Traders Association Deputy director Oh Hyun, Kwon

2006 Product Catalog. QA RA Compliance Connection, Inc. Highlighted Products: Quality System Training Modules. Informational Handbooks

Job Title: Head, Clinical Science Job Location: Nanjing, China CV to: Wechat:

STRATEGIC RESOURCING. inventivhealthclinical.com

Your German source for oncology products

Robbie Morehead Project Manager

Cardinal Health Specialty Solutions. Bringing a new drug to life. Regulatory Sciences

CGMP Requirements for Investigational Products

Job Openings at SoliPharma

ICH Q8/Q8(R)

Course Title ID Duration Basic Premium. Biological Evaluation of Medical Devices: A Risk-Based Approach N mins

Life Sciences Courseware. Knowledge. Performance. Impact.

How Should I Respond To This FDA Warning Letter (And Other Compliance Questions...

Investigational New Drug (IND) & Investigational Device Exemptions (IDE) Applications Preparation and Submission, and Conducting FDA Meetings

NUSAGE PharmEng. Pharmaceutical and Biotechnology Training Program COMPUTERIZED SYSTEM VALIDATION

Investigational New Drug (IND) & Investigational Device Exemptions (IDE) Applications Preparation and Submission, and Conducting FDA Meetings

When the FDA comes knocking, will your inspection be a success? YES

Established Conditions: Reportable CMC Changes for Approved Drug and Biologic Products Guidance for Industry

11.0 FDA-Regulated Research Research Involving Investigational Drugs and Biologics

BioPharm. Smart Outsourcing: Strategic Alignment, Risk Management, and New Relationships

Demystify Governance, Risk & Compliance For Lifesciences

MDI Manufacturing Services

Regulations in Pharmaceutical Laboratories

September 12, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852

Health Authority Inspection Management. GMP Inspection practices L. Mansolelli, Group Compliance & Auditing June 2012

T H E P R O P O S A L F O R T H E Y E A R

Flexible Partnership Solutions from Cambridge Global Payments

Experience with Health Canada s Approach for Post-Approval Changes. Kiran Krishnan Vice President US Regulatory Affairs September 2014

Information Governance for Data Integrity

Abbreviated WHO prequalification assessment procedure

Staffing - Medical Devices

Stability Studies for Pharmaceutical Products (API and finished products)

DFUG 2015 Audit Report

Advocate Health Care Network. Human Research Protection Program. Plan

11.0 FDA-Regulated Research Research Involving Investigational Drugs and Biologics

Re: Comments to FDA re Guidance Document on Data Integrity and Compliance with CGMP

Cleaning Validation-Common Errors

Inspection Trends. American Society for Quality Richmond, VA Section March 8, 2016

PDA & West Present: Combination Products Combination Product Hot Topics: Post Approval Device Changes and the New EU MDR Article 117 Requirements

Transcription:

Regulatory Affairs, Compliance Assurance, Quality Systems, Remediation Strategy and Support, and Strategic Consulting Services

At Regulatory Compliance Associates Inc. (RCA) we understand the complexities of the Pharmaceutical and Biopharmaceutical Industry. Our expertise spans all facets of R&D, Manufacturing Operations, Regulatory Affairs, Quality Assurance and Compliance. We are used to working on the front lines with our clients to help them navigate in a highly regulated industry. As your partners, we can negotiate the potential minefield of pharmaceuticals with insight, hindsight, and the clear advantage of our breadth and depth of knowledge and experience. REPRESENTATIVE EXAMPLES OF OUR EXPERTISE Product Categories Product Families (Indications) Product Types Sterile Parenteral Injectables Anesthesiology Small Molecules Lyophilized and Aseptic Powder Fill Analgesia Biologics Tablets/Capsules Anti-infectives Biosimilars Ready-To-Use Liquids Oncology Combination Products Novel Formulations Critical Care In vitro Diagnostics RCA enlists over 500 top industry experts, blending FDA veterans and seasoned regulatory affairs leaders. Who we help: Start-ups and Virtual Life Science Companies that want to leverage the benefits of outsourced services Fortune 100 multi-national companies to start-ups Companies new to FDA and pharmaceutical regulations Law firms seeking experts in remediation of 483 s, Warning Letters, Consent Decrees or Import bans Private equity and law firms seeking technical due diligence Regulatory Support for New Product Development Global Regulatory Strategy Global Submissions Meetings and Briefing Packages Pre-IND, Pre-NDA (BPD) Type-3 End of Phase 2 Advisory Committee Type A, B or C US and Global Submissions IND, DMF, BLA, ANDA NDA: 505(b)(1) & 505(b)(2) and Combination Products Orphan Designation, Fast Track and Expedited Review CEP and MAA RCA has an understanding of food and drug law coupled with the knowledge of the inner workings of FDA

Life Cycle Management Dossier Management Change Control ectd and Electronic Submission Capabilities to U.S., Canada and EU DMF Amendments and Annual Reports DMF Conversions to ectd Annual Reports and PADARs Supplements Changes Being Effective: CBE 0 & CBE 30 Prior Approval Supplements (PAS) Type I and Type II Variations (EU) Abbreviated New Drug Application (ANDA) *Changes introduced during LCM of any drug product Additional Regulatory Services RCA can also help with your unique Regulatory needs. We understand that it s not just the submissions and inspections where companies might need assistance, sometimes it s additional items needed to support your business operations. Outsourced Regulatory Affairs and Staff Augmentation DMF: (New or ectd Conversion) US Agent Services Regulatory Gap Assessment Due Diligence Site Registration Regulatory Affairs Training Electronic ectd Preparation and Submission Compliance Assurance Due Diligence Regulatory & Quality Due Diligence Facility / Equipment Assessment Personnel Assessment Post-Merger Integration 21 CFR Part 11, Annex 11 Assessment 21 CFR Part 210 & 211 Assessment cglp Assessment or Training Internal Audits, Contract Manufacturer Audits, Supplier Audits FDA Inspection Readiness & Training Regulatory Agency Action Response 483 Response Warning Letter Consent Decree Import Bans

Quality Systems Outsourced Quality Support Quality System Implementation Quality System Remediation / Improvement Risk Management ICH Q9 CAPA and Complaint System 21 CFR Part 210 and 211 Computerized System Validation Laboratory Support SOP Development Method Transfer Method Validation We would absolutely recommend RCA to set up and manage a quality system. We couldn t afford to hire personnel with RCA s expertise and our engagement allows us to tap into them as needed while we focus on growing the company. Vice President Operations Remediation Strategy and Support 21 CFR Part 210 & 211 Remediation Oversight Services for Manufacturing and Quality Services Data Integrity Services Regulatory Action Remediation 483 Remediation Warning Letter Remediation Consent Decree Remediation Manufacturing Process Equipment, Facility and Utility Validation Part 11 and Computerized System Validation Laboratory Support Top Drug 483 Observations October 1, 2015 - September 30, 2016 21 CFR 211.22(d) Procedures not in writing, fully followed 160 140 120 100 80 60 40 20 0 Number of Observations 21 CFR 211.160(b) Scientifically sound laboratory controls 21 CFR 211.192 Investigations of discrepancies, failures 21 CFR 211.100(a) Absence of Written Procedures 21 CFR 211.42(c)(10)(iv) Environmental Monitoring System

Strategic Consulting Services Manufacturing Process Optimization Automation and Aging Facilities Staffing Needs Staff Augmentation Project Team Change Management Changes to Comply with Standard Cost Reduction New Supplier Changes to Address Complaints Quality System Automation Using Software Master Validation Plan Mergers & Acquisition / Due Diligence Regulatory & Quality Due Diligence Facility/Equipment Assessment Personnel Assessment Post-Merger Integration RCA not only remediated our warning letter, but they also helped prepare our teams for an upcoming audit. We received no observations during the next FDA inspection. VP of Quality Why Choose RCA? We are widely recognized within the life science industry and by global regulatory agencies for our ability to help companies successfully deal with complex regulatory challenges. By mining regulatory intelligence, we continuously evaluate FDA s and other regulatory agencies current thinking and leverages thought leadership networks to advocate for our clients. We know a quality or compliance crisis can significantly impact your business. We have the experience to manage them. We have the know-how and proven approach to navigate Warning Letters, Consent Decrees and other situations. We know how to partner with your executive, legal and communication teams. We support management to assist with the growing and changing concerns. We help navigate the storm and manage the impact to your business. Quick Facts About RCA: Founded in 2000 Headquartered in Southeastern Wisconsin with offices in West Central Florida, Northern Colorado & Central Eastern Europe Expertise backed by over 500 industry and FDA subject matter experts Regulatory Submissions in 196 different countries / dependencies Engagements on four continents

You won t find a more talented team, a more personable group, or one more dedicated to your success than Regulatory Compliance Associates. Senior Manager of Corporate Reliability Engineering REGULATORY SUBMISSIONS IN 196 COUNTRIES /DEPENDENCIES ENGAGEMENTS ON 4 CONTINENTS OFFICES AT 4 LOCATIONS ISO 9001:2008 CERTIFIED RCA HEADQUARTERS 10411 Corporate Drive, Suite 102 Pleasant Prairie, WI 53158 SOUTHEAST REGIONAL OFFICE 720 Brooker Creek Blvd., Suite 201 Oldsmar, FL 34677 WESTERN REGIONAL OFFICE 1200 Pearl Street Suite 206 Boulder, CO 80302 EUROPEAN OFFICE ul. Postepu 15c 02-676 Warszawa, Polska PHONE: 262.288.6300 FAX: 262.842.1240 WEB: www.rcainc.com 2017 Regulatory Compliance Associates Inc. All Rights Reserved.